New web tool aims to keep low-risk prostate cancer patients on track
NCT ID NCT05764005
First seen Mar 13, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This pilot study tested a web-based tool called MAP to help men with low-risk prostate cancer stay on active surveillance. Active surveillance means closely monitoring the cancer instead of treating it right away. The study enrolled 39 men aged 55 and older and measured how well the tool worked and how satisfied patients were. The goal is to improve care by involving primary care doctors in the process.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.